Viral Shedding Dynamics in Vaccinated Vs Unvaccinated Populations with New Influenza Variants

Authors

  • Amna Basharat Ali Shaikh Zayed Hospital, Lahore, Pakistan
  • Ayra Muhammad Shaikh Zayed Hospital, Lahore, Pakistan
  • Abdul Rehman Shaikh Zayed Hospital, Lahore, Pakistan
  • Shakirullah Shaikh Zayed Hospital, Lahore, Pakistan
  • Muhammad Hadi Khan Department of Surgery, St. Luke's General Hospital, Kilkenny, Ireland
  • Khalid Mustafa Department of Pharmacology, Bahria University Health Sciences Campus Karachi, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i8.2648

Keywords:

Influenza vaccine, Viral shedding, Viral dynamics, Cycle threshold (Ct) value, Vaccine effectiveness, Infectious duration, Influenza variants, Clinical severity

Abstract

Background: Effectiveness of the annual influenza vaccine is mostly quantified by severe disease prevention but its role in influenza shedding dynamics and the period of infectivity, in particular against circulating variants, is a concern of critical importance in understanding the public health. The purpose of the present study was to compare the viral load, shedding period, and the severity of the clinical condition of vaccinated and unvaccinated adults with confirmed influenza infection. Methods: The participants in this observational cohort study (n=72) were evenly divided into two groups based on whether they were vaccinated or not with the influenza virus through laboratory tests (n=36 vaccinated and n=36 unvaccinated). There was close matching of participants in terms of baseline. Nares pharyngeal swabs were taken on a daily basis up to 10 days or until two consecutive negative RT-PCR results were achieved. The results were viral load (Ct values), viral decline rate, total shedding time, culture positive and measures of clinical severity (duration of symptoms and incidence of moderate-severe illness). Results: There was a similarity between groups in terms of baseline characteristics (p > 0.42 all). Viral control was better in the vaccinated group where both the baseline and peak viral load was significantly lower (p=0.002 and p=0.004) and the rate of viral decline was also much faster (2.8 +- 0.6 Ct/day vs 1.9 +- 0.5 Ct/day, p<0.001). Most importantly, there was an association between vaccination and decreased Total Shedding Duration (4.8 ± 1.3 vs 7.1 ± 1.8 days, p<0.001), and there was less culture positive on Day 5 (19.4% vs 61.1%, p<0.001). There was a significantly long period of symptoms and lower occurrence of moderate-to-severe illness amongst the vaccinated participants (16.7% vs 38.9%, p=0.03). The shielding property on shedding time was strongly seen in all three variants experimented. Conclusion: Vaccination against influenza has a great influence on reducing the depth and durability of the illness resulting in a reduced viral load and a considerably reduced period of contagion. These results support the importance of the vaccine to minimize the personal disease burden, as well as the possibility of infection of the community, even with the presence of new influenza strains.

Downloads

Download data is not yet available.

References

1. Kissler, S.M., et al., Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated individuals. 2021: p. 2021.02. 16.21251535.

https://doi.org/10.1101/2021.02.16.21251535

2. Jung, J., et al., Transmission and infectious SARS-CoV-2 shedding kinetics in vaccinated and unvaccinated individuals. 2022. 5(5): p. e2213606-e2213606.

https://doi.org/10.1001/jamanetworkopen.2022.13606

3. Fisman, D.N., A. Amoako, and A.R.J.C. Tuite, Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission. 2022. 194(16): p. E573-E580.

https://doi.org/10.1503/cmaj.212105

4. Everett, H.E., et al., Vaccines that reduce viral shedding do not prevent transmission of H1N1 pandemic 2009 swine influenza a virus infection to unvaccinated pigs. 2021. 95(4)

https://doi.org/10.1128/jvi.01787-20

5. Garcia-Knight, M., et al., Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study. 2022. 18(9): p. e1010802.

https://doi.org/10.1371/journal.ppat.1010802

6. Puhach, O., et al., Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron. 2022: p. 2022.01. 10.22269010.

https://doi.org/10.21203/rs.3.rs-1293087/v1

7. Riemersma, K.K., et al., Shedding of infectious SARS-CoV-2 despite vaccination. 2022. 18(9): p. e1010876.

https://doi.org/10.1371/journal.ppat.1010876

8. Luo, C.H., et al., Infection with the SARS-CoV-2 delta variant is associated with higher infectious virus loads compared to the alpha variant in both unvaccinated and vaccinated individuals. 2021.

https://doi.org/10.1101/2021.08.15.21262077

9. Puhach, O., et al., Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. 2022. 28(7): p. 1491-1500.

https://doi.org/10.1038/s41591-022-01816-0

10. Bell, G.J.m., Evolutionary dynamics of a virus in a vaccinated population. 2021: p. 2021.08. 19.21262307.

https://doi.org/10.1101/2021.08.19.21262307

11. Viboud, C., et al., Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine. 2020. 16(9): p. e1008583.

https://doi.org/10.1371/journal.ppat.1008583

12. Kandel, C., et al., Viral dynamics of the SARS-CoV-2 Omicron Variant among household contacts with 2 or 3 COVID-19 vaccine doses. 2022. 85(6): p. 666-670.

https://doi.org/10.1016/j.jinf.2022.10.027

13. Deblanc, C., et al., Evaluation of the pathogenicity and the escape from vaccine protection of a new antigenic variant derived from the European human-like reassortant swine H1N2 influenza virus. 2020. 12(10): p. 1155.

https://doi.org/10.3390/v12101155

14. Kang, M., et al., Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021. 2022. 27(10): p. 2100815.

https://doi.org/10.2807/1560-7917.es.2022.27.10.2100815

15. Chase-Topping, M., et al., New insights about vaccine effectiveness: Impact of attenuated PRRS-strain vaccination on heterologous strain transmission. 2020. 38(14): p. 3050-3061.

https://doi.org/10.1016/j.vaccine.2020.02.015

16. Li, C., et al., Vaccination decreases the risk of influenza A virus reassortment but not genetic variation in pigs. 2022. 11: p. e78618.

https://doi.org/10.7554/elife.78618

17. Cobey, S., et al., Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination. 2021. 21(5): p. 330-335.

https://doi.org/10.1038/s41577-021-00544-9

18. Lipsitch, M., et al., SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact. 2022. 22(1): p. 57-65.

https://doi.org/10.1038/s41577-021-00662-4

19. Yang, W., E.H. Lau, and B.J.J.P.c.b. Cowling, Dynamic interactions of influenza viruses in Hong Kong during 1998-2018. 2020. 16(6): p. e1007989.

https://doi.org/10.1371/journal.pcbi.1007989

20. Li, C., Influenza prime-boost vaccination, diversity, and evolution in pigs. 2022, University of Minnesota.

Downloads

Published

2025-08-30

How to Cite

Ali, A. B., Muhammad, A., Abdul Rehman, Shakirullah, Khan, M. H., & Mustafa, K. (2025). Viral Shedding Dynamics in Vaccinated Vs Unvaccinated Populations with New Influenza Variants. Indus Journal of Bioscience Research, 3(8), 586-590. https://doi.org/10.70749/ijbr.v3i8.2648